Efficacy of Shunthyadi Aschyotana (Eye Drop) and Mahatriphaladi Ghrita Pana (Orally) in the management of Dry Eye (Due to excessive use of Visual Display Terminal (VDT) gadgets)

Efficacy of Shunthyadi Aschyotana (Eye Drop) with and without Mahatriphaladi Ghrita Pana (Orally) in the management of Dry Eye (Due to excessive use of Visual Display Terminal (VDT) gadgets)- An Open Labelled Randomized Comparative Clinical Trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/02/040279

Enrollment

Registered

2022-02-14

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H049- Disorder of lacrimal system, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients in the age group 18-50 years irrespective of sex, caste, religion. 2.Patients having minimum three symptoms of Dry Eye (Due to Excessive use of Visual Display Terminal (VDT) Gadgets. 3.Minimum 1 hour exposure to any type of Visual Display Terminal (VDT) like desktop, laptop or mobile screens. 4.Patients having minimum 2 findings of below tests: a.Schirmer strip wetting of between 1-15 mm in 5 minutes Schirmer- I test. b.The appearance of dry spot between 1-15 seconds- Fluorescein Tear Film Break Up Test (F-TBUT). c.Mild to Severe Staining (Superficial to dense staining) - Fluorescein Staining. d.Mild to Severe Staining (Dot count 1-30) - Rose Bengal Staining (Oxford scheme of scoring)

Exclusion criteria

Exclusion criteria: 1.Age less than 18 years and more than 50 years. 2.Dry Eye due to any local cause e.g., Allergic Conjunctivitis, Xerosis etc. 3.Dry Eye due to systemic disease like Sjogren’s Syndrome. 4.Patients on Steroids, Oral Contraceptive Pills, Estrogen Replacement Therapy or any other medication such as Antispasmodic drugs like Atropine that may adversely affect the outcome of the study. 5.Persistent contact lens users. 6.Patients having chronic debilitating diseases like HIV, Tuberculosis, Malignancy, uncontrolled Diabetes Mellitus and Hypertensive.

Design outcomes

Secondary

Measure	Time frame
Relief in Signs and Symptoms of Dry Eye (Due to excessive use of Visual Display Terminal (VDT) gadgets)Timepoint: Relief in Signs and Symptoms of Dry Eye (Due to excessive use of Visual Display Terminal (VDT) gadgets) with in 4-6 weeks.	—

Primary

Measure	Time frame
Relief in Signs and Symptoms of Dry Eye (Due to excessive use of Visual Display Terminal (VDT) gadgets).Timepoint: Relief in Signs and Symptoms of Dry Eye (Due to excessive use of Visual Display Terminal (VDT) gadgets) within 4-6 weeks.	—

Countries

India

Contacts

Public ContactDr Deepak Pawar

Institute of Teaching and Research in Ayurveda

drdeep29@gmail.com7737379173

Outcome results